论文信息 - STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC) - 字舞流文

STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC)

M. Makuuchi | V. Mazzaferro | M. Kudo | J. Bruix | J. Llovet | H. Lee | L. Bolondi | G. Meinhardt | R. Poon | Jiamei Yang | T. Takayama | G. Chau | W. Tak | S. Roayaie | K. Han | T. Song | J. Cai | K. Lee | F. Souza | Marie-Aude Le Berre | S. Investigators | M. Berre